Pharmaceutical Business Review Latest NewsLatest news from Pharmaceutical Business ReviewSectra signs installation agreement with Sergas- July 7, 2008 Sectra, an IT and medical-technology company, has signed an agreement with Sergas, a provider of healthcare services for Galicia region in the northwest of Spain, to install PACS at five of the region's public hospitals.http://www.pharmaceutical-business-review.com/article_news.asp?guid=67ACD2AF-B18A-4C66-8A8... Cell Biosciences appoints key executives- July 7, 2008 Cell Biosciences, a provider of ultra sensitive protein detection and characterization systems to life science researchers, has appointed Jason Novi as its new CFO.http://www.pharmaceutical-business-review.com/article_news.asp?guid=C5A7EC44-2CC2-462B-9C4... BD Diagnostics granted CE Mark for GeneOhm Cdiff molecular assay- July 7, 2008 BD Diagnostics, a segment of Becton Dickinson and Company, has received CE mark for BD GeneOhm Cdiff molecular assay for the rapid diagnosis of patients with Clostridium difficile infection.http://www.pharmaceutical-business-review.com/article_news.asp?guid=3CC0A263-2889-4D4B-826... Fresenius to acquire APP Pharmaceuticals- July 7, 2008 Fresenius, a provider of dialysis and home medical care products, and APP Pharmaceuticals have entered into a definitive merger agreement pursuant to which Fresenius will acquire APP.http://www.pharmaceutical-business-review.com/article_news.asp?guid=238040BF-7950-4B59-845... Ceapro's CEO and president to step down- July 7, 2008 Ceapro has announced that Mark Redmond has decided to step down as a director and an officer of the company, effective immediately.http://www.pharmaceutical-business-review.com/article_news.asp?guid=B915BC33-6E3C-4622-A06... Teva's Phase III multiple sclerosis study trial fails to demonstrate increased efficacy- July 7, 2008 Teva Pharmaceutical Industries has reported results from a Phase III study designed to assess the efficacy, safety and tolerability of glatiramer acetate 40mg as compared to the approved Copaxone 20mg in the treatment of relapsing-remitting multiple sclerosis.http://www.pharmaceutical-business-review.com/article_news.asp?guid=03E2030C-43DD-42F8-B48... Probio to acquire Gelkaps- July 7, 2008 Probio Nutraceuticals has entered into an agreement to acquire Gelkaps, which manufactures pharmaceutical and nutraceutical grade soft gelatin capsules.http://www.pharmaceutical-business-review.com/article_news.asp?guid=C7026B7E-566E-4928-942... InTouch Health launches new stroke care solution- July 7, 2008 InTouch Technologies, doing business as InTouch Health, has launched its new product feature, StrokeRespond, to extend the functionality of its remote presence robotic technology for stroke experts.http://www.pharmaceutical-business-review.com/article_news.asp?guid=EA06D7F6-E0B4-40C6-AAB... Axolotl appoints new marketing director- July 7, 2008 Axolotl, a provider of health information exchange technology solution, has named Carol Somer as its new marketing director.http://www.pharmaceutical-business-review.com/article_news.asp?guid=45393FB8-E7F7-4C1B-891... Vitrolife increases stake in ATS- July 7, 2008 Vitrolife, a biotechnology and medical device company, has acquired a further 9% of the shares in ATS, the distributor of Vitrolife's products in Italy.http://www.pharmaceutical-business-review.com/article_news.asp?guid=6627363C-CFDD-4544-969... |